1. Effectiveness of CAR-T treatment toward the potential risk of second malignancies.
- Author
-
Martino, Massimo, Porto, Gaetana, Policastro, Giorgia, Alati, Caterina, Loteta, Barbara, Micó, Maria Caterina, Argiro', Clizia, Altomonte, Maria, Moscato, Tiziana, Labate, Demetrio, Dattola, Vincenzo, Rao, Carmelo Massimiliano, Cogliandro, Francesca, Canale, Filippo Antonio, Naso, Virginia, Filippelli, Gianfranco, Iaria, Antonino, and Pitea, Martina
- Subjects
TREATMENT effectiveness ,TUMOR lysis syndrome ,SKIN cancer ,HEMATOPOIETIC stem cell transplantation - Abstract
This document provides a list of references to studies and articles related to CAR-T cell therapy for various types of lymphoma and multiple myeloma. The studies mentioned discuss the outcomes, safety, and efficacy of CAR-T cell therapies such as lisocabtagene maraleucel, axicabtagene ciloleucel, brexucabtagene autoleucel, ciltacabtagene autoleucel, and idecabtagene vicleucel. The document also includes references to studies that discuss the potential risk of secondary malignancies and other long-term effects associated with CAR-T cell therapy. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF